Prosecution Insights
Prosecution Insights
7 pending office actions • 4 art units • 7 examiners • 0 of 7 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (14%) |
| §103 only | 2 (29%) |
| §102 only | 1 (14%) |
| Multi-statute (no §101) | 3 (43%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BRAUN, MADELINE E | 1 | 67.6% | +26.4% |
| PECKHAM, RICHARD GRANT | 1 | 67.2% | +37.0% |
| INAM, SAHAR | 1 | 100.0% | +0.0% |
| RODRIGUEZ-GARCIA, VALERIE | 1 | 68.8% | +31.9% |
| WILLIS, DOUGLAS M | 1 | 82.4% | +19.5% |
| VISHNYAKOVA, ELENA VLADIMIROVNA | 1 | 62.9% | +60.8% |
| YOO, SUN JAE | 1 | 71.0% | +0.3% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18688647 | COMPOUND FOR DEGRADATION OF BCL-2 FAMILY PROTEINS AND MEDICAL APPLICATION THEREOF | INAM, SAHAR | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18269670 | FIVE-MEMBERED RING DERIVATIVE AND MEDICAL USE THEREOF | WILLIS, DOUGLAS M | 8d overdue |
| 18836748 | POLYMORPH AS THYROID HORMONE RECEPTOR AGONISTS AND USE THEREOF | BRAUN, MADELINE E | — |
| 18579733 | AAK1 INHIBITOR AND USE THEREOF | RODRIGUEZ-GARCIA, VALERIE | — |
| 18254374 | BENZENE RING DERIVATIVE, AND COMPOSITION AND PHARMACEUTICAL USE THEREOF | VISHNYAKOVA, ELENA VLADIMIROVNA | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18269670 | FIVE-MEMBERED RING DERIVATIVE AND MEDICAL USE THEREOF | WILLIS, DOUGLAS M | 8d overdue |
| 18836748 | POLYMORPH AS THYROID HORMONE RECEPTOR AGONISTS AND USE THEREOF | BRAUN, MADELINE E | — |
| 18836350 | PREPARATION METHOD OF PYRIDAZINONE DERIVATIVE, AND INTERMEDIATE THEREOF | PECKHAM, RICHARD GRANT | — |
| 18579733 | AAK1 INHIBITOR AND USE THEREOF | RODRIGUEZ-GARCIA, VALERIE | — |
| 18254374 | BENZENE RING DERIVATIVE, AND COMPOSITION AND PHARMACEUTICAL USE THEREOF | VISHNYAKOVA, ELENA VLADIMIROVNA | — |
| Art Unit | Apps |
|---|---|
| 1621 | 2 |
| 1622 | 1 |
| 1624 | 1 |
| 1691 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18836748 | POLYMORPH AS THYROID HORMONE RECEPTOR AGONISTS AND USE THEREOF | BRAUN, MADELINE E | — | §101§102§103§112 | Non-Final OA | — | Pending | Aug 07, 2024 |
| 18836350 | PREPARATION METHOD OF PYRIDAZINONE DERIVATIVE, AND INTERMEDIATE THEREOF | PECKHAM, RICHARD GRANT | — | §103 | Non-Final OA | — | Pending | Aug 06, 2024 |
| 18688647 | COMPOUND FOR DEGRADATION OF BCL-2 FAMILY PROTEINS AND MEDICAL APPLICATION THEREOF | INAM, SAHAR | 1622 | §103 | Non-Final OA | — | Pending | Mar 01, 2024 |
| 18579733 | AAK1 INHIBITOR AND USE THEREOF | RODRIGUEZ-GARCIA, VALERIE | 1621 | §102§103§112 | Non-Final OA | — | Pending | Jan 16, 2024 |
| 18269670 | FIVE-MEMBERED RING DERIVATIVE AND MEDICAL USE THEREOF | WILLIS, DOUGLAS M | 1624 | §102§112 | Non-Final OA | 8d overdue | Pending | Jun 26, 2023 |
| 18254374 | BENZENE RING DERIVATIVE, AND COMPOSITION AND PHARMACEUTICAL USE THEREOF | VISHNYAKOVA, ELENA VLADIMIROVNA | 1691 | §103§112 | Final Rejection | — | Pending | May 24, 2023 |
| 18015309 | PB2 INHIBITOR, AND PREPARATION METHOD THEREFOR AND USE THEREOF | YOO, SUN JAE | 1621 | §102 | Final Rejection | 39d | Pending | Jan 09, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial